Hookipa Pharma has ended discussions to join forces with Poolbeg Pharma and create a NASDAQ-listed entity, in a move first mooted on 2 January.
The decision has left Poolbeg, which has headquarters in the UK and Ireland, “surprised and disappointed,” said its executive chairman,